Labiotech.eu

News and Trends 14 Feb 2020

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

The Danish industrial biotech company Novozymes has announced the launch of its latest non-GM yeast technology, Innova Fit, which it says reduces biofuel production bottlenecks caused by conventional and basic yeast. Biofuels, including ethanol, are a renewable energy source being used as a replacement for fossil fuels, with substantially reduced CO2 emissions, particularly in the transport […]

February 14, 2020 - 3 minutesmins - By External Contributor

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence. The three-year partnership will use artificial intelligence, or AI, in six programs designed to accelerate the development of therapeutic monoclonal antibodies (mAbs) that can target cancer and autoimmune diseases. AI can improve the efficiency of […]

February 13, 2020 - 2 minutesmins - By External Contributor

automation arctoris molecule drug discovery

News and Trends 13 Feb 2020

UK-Swiss Collaboration to Boost Biotech Profits with Automation

A partnership between the UK lab automation company Arctoris and Swiss software firm Molecule aims to make it easier to share drug intellectual property in a time of declining returns in pharma. The pharmaceutical industry is struggling with the rising costs of developing new drugs. In fact, the return on investment for drug discovery is […]

February 13, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 12 Feb 2020

Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics

Ingestible pellets containing a charcoal-like treatment — designed by the French company Da Volterra — can stop the microbiome from being disrupted in hospitalized patients treated with antibiotics. The treatment also showed the potential to reduce the risk of Clostridium difficile gut infections in a phase II trial. When patients are given antibiotics for infections, […]

February 12, 2020 - 2 minutesmins - By Jonathan Smith

Interview 12 Feb 2020

Boosting Cancer Research by Unlocking Genomic Data

More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although there is a lot of data out there, much of it is inaccessible. With a background in computer science and bioinformatics, Fiona Nielsen, co-founder and CEO of Repositive, decided to overcome this bottleneck and open […]

February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin

stilla technologies pcr molecular diagnostics

News and Trends 11 Feb 2020

French Biotech Raises €20M to Make Precision Molecular Diagnostics

Stilla Technologies has raised a €20M Series C round to fund its mission to produce next-generation microchips that make molecular diagnostics more precise and user-friendly than currently available lab technology. Contributors to the round included Stilla’s existing investors, such as Illumina Ventures, Kurma Partners and Idinvest Partners. Stilla also added the Chinese company TUS-Holdings to […]

February 11, 2020 - 2 minutesmins - By Jonathan Smith

In Depth 11 Feb 2020

Why European Biotechs Should Look to China for Investment

Traditionally European biotechs have looked to the US for additional investment, but changes in the law and significant economic success in the country in recent years means that new opportunities are opening up in China that are ripe for exploitation. China has a massive population and a correspondingly large patient group. Homegrown science is pretty […]

February 11, 2020 - 8 minutesmins - By Helen Albert

lysosomal storage disorders azafaros rare disease

News and Trends 10 Feb 2020

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

The Dutch startup Azafaros has raised €25M in Series A funding to push its drug for inherited lysosomal storage disorders into phase I. The round was led by the Dutch VC firm Forbion. Other investors participating in the round included the Swiss firm BioMedPartners and the Dutch company BioGeneration Ventures, which was Azafaros’ founding investor […]

February 10, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 10 Feb 2020

Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding

Bayer and the French biotech company Meiogenix will work together to advance the development of Meiogenix’s plant breeding and genome editing technologies with the hope of improving food crops for farmers. For many years, the only way to improve characteristics such as yield and nutritional value of crops was through selective breeding, which can be […]

February 10, 2020 - 3 minutesmins - By External Contributor

sigrid therapeutics type 2 diabetes sweden

Startup Scout 7 Feb 2020

Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut

In Stockholm, Sweden, Sigrid Therapeutics is developing an ingestible silica powder that can treat type 2 diabetes and obesity without being absorbed in the gut. Mission: To produce the first prophylactic silica-based treatment for type 2 diabetes that does not enter the bloodstream. Some people have higher blood sugar levels than normal, but not high […]

February 7, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Feb 2020

EU Project Set up to Fight Alzheimer’s Disease with Lasers

A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s and Huntington’s disease by making brain cells controllable with red light. There are currently no treatments approved that can slow the progression of neurodegenerative conditions, including Alzheimer’s and Huntington’s disease. Treatments approved to alleviate the symptoms only help a small […]

February 7, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Feb 2020

Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools

Swiss company Lunaphore Technologies has raised €21.5M (CHF 23M) in Series C funding to expand the automation of cancer research and tissue diagnostics in Europe and the US. The oversubscribed funding round was completed in mid-January and was led by Japan-based PHC Holdings Corporation, with further contributions from existing investors including Redalpine Venture Partners, OCCIDENT […]

February 6, 2020 - 2 minutesmins - By External Contributor

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

French Partnership Deploys AI for Antibody Drug Discovery

UK-Swiss Collaboration to Boost Biotech Profits with Automation

Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics

Boosting Cancer Research by Unlocking Genomic Data

French Biotech Raises €20M to Make Precision Molecular Diagnostics

Why European Biotechs Should Look to China for Investment

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding

Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut

EU Project Set up to Fight Alzheimer’s Disease with Lasers

Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!